Litigation (Details) - USD ($)					3 Months Ended					12 Months Ended
		Apr. 18, 2025	Feb. 06, 2025	Jul. 31, 2024	Mar. 31, 2025	Dec. 31, 2024	Jun. 30, 2024	Mar. 31, 2024	Dec. 31, 2022	Dec. 31, 2024	Jul. 02, 2024
Commitments and Contingencies Disclosure [Line Items]
Other assets					$ 13,100,000	$ 18,900,000				$ 18,900,000
Revenue					222,200,000			$ 300,400,000
Cost of goods and services sold	[1]				88,500,000			144,600,000
Product and services sales, net
Commitments and Contingencies Disclosure [Line Items]
Revenue					$ 209,100,000			$ 292,400,000
Jansen Pharmaceuticals, Inc.
Commitments and Contingencies Disclosure [Line Items]
Proceeds from legal settlements				$ 50,000,000
Increase in other assets									$ 152,700,000
Other assets						0				0	$ 158,700,000
Cost of goods and services sold							$ 50,000,000
Inventory write-offs							110,200,000
Jansen Pharmaceuticals, Inc. | Product and services sales, net
Commitments and Contingencies Disclosure [Line Items]
Revenue							$ 50,000,000
Securities And Shareholder Litigation
Commitments and Contingencies Disclosure [Line Items]
Damages paid						40,000,000
Damages paid from insurance proceeds						30,000,000
Settlement period			20 days
Implementation reforms, period			60 days
Period of reforms to be maintained			4 years
Settlement amount			$ 15,000,000
SEC Enforcement Proceeding
Commitments and Contingencies Disclosure [Line Items]
Loss contingency accrual, provision										1,500,000
Loss contingency, accrual, current						$ 1,500,000				$ 1,500,000
SEC Enforcement Proceeding | Subsequent Event
Commitments and Contingencies Disclosure [Line Items]
Payments for legal settlements		$ 1,500,000

[1] (1) Exclusive of intangible asset amortization